Lorena Arranz

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAtmospheric aerosolsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 05, 2026
Succinate receptor 1 restricts hematopoiesis and prevents acute myeloid leukemia progression.

Vincent Cuminetti, Emeline Boet, Marcel Heugel

|Jun 30, 2023
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.

Alicia Villatoro, Vincent Cuminetti, Aurora Bernal

|Jan 03, 2023
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.

Alicia Villatoro, Vincent Cuminetti, Aurora Bernal

|Sep 02, 2022
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells.

Nuria Vilaplana-Lopera, Vincent Cuminetti, Ruba Almaghrabi

|Feb 15, 2022
The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies.

Lorena Arranz

|Sep 28, 2021
Female Mice Reaching Exceptionally High Old Age Have Preserved 20S Proteasome Activities.

Irene Martínez de Toda, Suresh I S Rattan, Mónica De la Fuente

Pageof 2

Frequent Collaborators

5 joint publications

Vincent Cuminetti

3 joint publications

Ruth H Paulssen

3 joint publications

Fátima Sánchez-Cabo

3 joint publications

Aurora Bernal